GenoMed4ALL ‐ Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases

GENOMED4ALL is a project with 23 participants and it is coordinated by UPM.

GENOMED4ALL will make use of the existing infrastructures and initiatives, including powerful High-Performance Computing facilities, hospital registries, data processing tools, and pre-existing repositories towards facilitating personalised medicine in common, rare and ultrarare haematological diseases to demonstrate the versatility and utility of the solutions. For doing this, GENOMED4ALL counts with the participation from ERN-EuroBloodNet.

GENOMED4ALL will start by leveraging on ERN-EuroBloodNet healthcare information and repositories that will be gathered through European Rare Blood Disorders Platform (ENROL), besides growing to incorporate other repositories in the project lifetime from public or private sources. The strategy defined is to start to integrate the 10 clinical partners repositories involved in the project to later enlarge it to the overall ERN-EuroBloodNet 66 relevant clinical repositories in 15 Member States, besides 20 repositories not present in EuroBloodNet.

GENOMED4ALL will demonstrate the potential and benefits of trustable and explainable AI technologies, with a novel approach to AI models and algorithms to exploit the powerful set of "-omics" data which will be at researchers' disposal leading to more reliable and meaningful outcomes for advancing research and personalised medicine, with 3 use cases covering oncological and non-oncological Haematological Diseases, including: Myelodysplastic syndromes, Multiple Myeloma, and Sickle Cell Disease.